Immunomedics, Inc., (NASDAQ: IMMU) announced that Dr. Charles Baum, President and Chief Executive Officer (CEO) of Mirati Therapeutics, Inc ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Changes Management Comments

After-Hours Movers 02/25: (HTZ) (THC) (ETSY) Higher; (VTGN) (NVCN) (IMMU) (more...)February 25, 2019 6:00 PM Immunomedics (IMMU) Misses Q2 EPS by 50cFebruary 25, 2019 4:35 PM Immunomedics (IMMU) CEO Steps DownFebruary 25, 2019 4:16 PM Immunomedics Reports Results For Period Ended December 31, 2018, Strengthens Board And Announces Senior Leadership ChangesFebruary 25, 2019 4:01 PM